FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2046007784> ?p ?o ?g. }

• W2046007784 endingPage "36" @default.
• W2046007784 startingPage "33" @default.
• W2046007784 abstract "The aim of this study was to evaluate whether there was a relationship between severity of multiple sclerosis (MS) exacerbation and pulmonary function test (PFT) and to determine the effect of theophylline, which was added to intravenous methylprednisolone, on serum Tumor Necrosis Factor (TNF)-alpha levels and clinical scores in MS relapses.Double blind randomized controlled trial.The baseline Expanded Disability Status Scale (EDSS) score was determined, PFT was performed and blood was taken for analysis of TNF- alpha in patients with MS exacerbation. Patients were randomly divided into two groups; group 1 received intravenous methylprednisolone+IV theophylline and group 2 intravenous methylprednisolone+placebo for 5 days. PFT and EDSS score were repeated and blood was taken for TNF-alpha on the 5(th) and 30(th) days of the treatment.Twenty-four patients (14 female, 10 male) were included in the study. Mean age was 32.6±9, duration of disease was 5.4±4.2 years, number of exacerbations was 5±2. There was a significant correlation between the number of exacerbations and EDSS score (p=0.000, r=1). Restrictive PFT findings were detected in 8 and decrease in carbon monoxide diffusing capacity (DLCO) in 3 cases. In within-group analysis, EDSS score was found to be decreased on day 5 and still low on day 30 in the theophylline group (baseline 3±1.3; 5(th) day 2.4±1.6; 30(th) day 2±1.7). There was no statistically significant difference in the EDSS score of the placebo group (3±1.6; 2.8±1.7; 2.4±1.9 respectively). While serum TNF-alpha level was not changed in the placebo group, there was a non-significant decrease on day 5 and increase on day 30 in the theophylline group. There was no correlation between the clinical parameters, PFT and TNF-alpha level.There was no correlation between severity of MS and PFT findings. It is suggested that theophylline might be effective in MS exacerbations since it caused decreases in clinical scores; studies with longer treatment duration are needed to clarify its possible anti-inflammatory effect." @default.
• W2046007784 created "2016-06-24" @default.
• W2046007784 creator A5021317314 @default.
• W2046007784 creator A5049640526 @default.
• W2046007784 creator A5059392492 @default.
• W2046007784 creator A5062214061 @default.
• W2046007784 creator A5064562758 @default.
• W2046007784 creator A5080153958 @default.
• W2046007784 date "2013-03-05" @default.
• W2046007784 modified "2023-10-01" @default.
• W2046007784 title "The Effect of Pulse Methylprednisolone Plus Theophylline Treatment on Clinical, Pulmonary and Inflammatory Markers in Relapses of Multiple Sclerosis" @default.
• W2046007784 cites W12264453 @default.
• W2046007784 cites W152465220 @default.
• W2046007784 cites W1555627355 @default.
• W2046007784 cites W186695524 @default.
• W2046007784 cites W1982303846 @default.
• W2046007784 cites W1988098374 @default.
• W2046007784 cites W1993814781 @default.
• W2046007784 cites W2000872418 @default.
• W2046007784 cites W2003600964 @default.
• W2046007784 cites W2005771731 @default.
• W2046007784 cites W2014133471 @default.
• W2046007784 cites W2043324060 @default.
• W2046007784 cites W2049761557 @default.
• W2046007784 cites W2053066468 @default.
• W2046007784 cites W2056247034 @default.
• W2046007784 cites W2072199622 @default.
• W2046007784 cites W2074419409 @default.
• W2046007784 cites W2077951941 @default.
• W2046007784 cites W2095799455 @default.
• W2046007784 cites W2125379328 @default.
• W2046007784 cites W2136163166 @default.
• W2046007784 cites W2136325849 @default.
• W2046007784 cites W2411772144 @default.
• W2046007784 cites W2916040650 @default.
• W2046007784 doi "https://doi.org/10.5152/balkanmedj.2013.004" @default.
• W2046007784 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4116016" @default.
• W2046007784 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25207066" @default.
• W2046007784 hasPublicationYear "2013" @default.
• W2046007784 type Work @default.
• W2046007784 sameAs 2046007784 @default.
• W2046007784 citedByCount "1" @default.
• W2046007784 countsByYear W20460077842017 @default.
• W2046007784 crossrefType "journal-article" @default.
• W2046007784 hasAuthorship W2046007784A5021317314 @default.
• W2046007784 hasAuthorship W2046007784A5049640526 @default.
• W2046007784 hasAuthorship W2046007784A5059392492 @default.
• W2046007784 hasAuthorship W2046007784A5062214061 @default.
• W2046007784 hasAuthorship W2046007784A5064562758 @default.
• W2046007784 hasAuthorship W2046007784A5080153958 @default.
• W2046007784 hasBestOaLocation W20460077841 @default.
• W2046007784 hasConcept C126322002 @default.
• W2046007784 hasConcept C142724271 @default.
• W2046007784 hasConcept C16020263 @default.
• W2046007784 hasConcept C165637977 @default.
• W2046007784 hasConcept C168563851 @default.
• W2046007784 hasConcept C203014093 @default.
• W2046007784 hasConcept C204787440 @default.
• W2046007784 hasConcept C27081682 @default.
• W2046007784 hasConcept C2776042228 @default.
• W2046007784 hasConcept C2777014857 @default.
• W2046007784 hasConcept C2777714996 @default.
• W2046007784 hasConcept C2778095195 @default.
• W2046007784 hasConcept C2780372218 @default.
• W2046007784 hasConcept C2780640218 @default.
• W2046007784 hasConcept C2780892749 @default.
• W2046007784 hasConcept C3018587741 @default.
• W2046007784 hasConcept C42219234 @default.
• W2046007784 hasConcept C71924100 @default.
• W2046007784 hasConcept C75603125 @default.
• W2046007784 hasConcept C90924648 @default.
• W2046007784 hasConceptScore W2046007784C126322002 @default.
• W2046007784 hasConceptScore W2046007784C142724271 @default.
• W2046007784 hasConceptScore W2046007784C16020263 @default.
• W2046007784 hasConceptScore W2046007784C165637977 @default.
• W2046007784 hasConceptScore W2046007784C168563851 @default.
• W2046007784 hasConceptScore W2046007784C203014093 @default.
• W2046007784 hasConceptScore W2046007784C204787440 @default.
• W2046007784 hasConceptScore W2046007784C27081682 @default.
• W2046007784 hasConceptScore W2046007784C2776042228 @default.
• W2046007784 hasConceptScore W2046007784C2777014857 @default.
• W2046007784 hasConceptScore W2046007784C2777714996 @default.
• W2046007784 hasConceptScore W2046007784C2778095195 @default.
• W2046007784 hasConceptScore W2046007784C2780372218 @default.
• W2046007784 hasConceptScore W2046007784C2780640218 @default.
• W2046007784 hasConceptScore W2046007784C2780892749 @default.
• W2046007784 hasConceptScore W2046007784C3018587741 @default.
• W2046007784 hasConceptScore W2046007784C42219234 @default.
• W2046007784 hasConceptScore W2046007784C71924100 @default.
• W2046007784 hasConceptScore W2046007784C75603125 @default.
• W2046007784 hasConceptScore W2046007784C90924648 @default.
• W2046007784 hasIssue "1" @default.
• W2046007784 hasLocation W20460077841 @default.
• W2046007784 hasLocation W20460077842 @default.
• W2046007784 hasLocation W20460077843 @default.
• W2046007784 hasLocation W20460077844 @default.
• W2046007784 hasLocation W20460077845 @default.
• W2046007784 hasOpenAccess W2046007784 @default.

• next